KYTX — Kyverna Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Kyverna Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS/A	PROSPECTUS/A	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	76.1	51.3	57.5	286	279
Prepaid Expenses
Total Current Assets	77.1	53.3	60.7	291	283
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.81	12.4	10.6	10.7	5.42
Other Long Term Assets
Total Assets	85.5	66.9	75.2	305	294
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.9	12	19.9	33.8	36.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	23	20.2	26	38.1	61.5
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	62.5	46.7	49.2	267	232
Total Liabilities & Shareholders' Equity	85.5	66.9	75.2	305	294
Total Common Shares Outstanding